Inhibition of VEGFR2, either by a cell-permeable kinase inhibitor, or anti-VEGF antibody treatment that acts externally, induced apoptosis in AML cells; however, the intracellular kinase inhibitor had a much stronger proapoptotic effect. This evidence concerns the gene VEGFA and acute myeloid leukemia.